3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
10
Phase 3
8
Phase 1/2
8
Phase 1
8
Phase NA
7
Phase 4
1
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
88
Lung Neoplasms
70
Small Cell Lung Carcinoma
11
Pleural Effusion, Malignant
9
Melanoma
7
Ovarian Neoplasms
6
NSCLC
6
Pleural Effusion
5
Neoplasms
5
Head and Neck Neoplasms
5
Stomach Neoplasms
4
Mesothelioma
4
Lung Diseases
4
Carcinoma, Renal Cell
4
Carcinoma
4
Breast Neoplasms
4
Uterine Cervical Neoplasms
3
Thoracic Neoplasms
3
Pneumothorax
3
Pleural Neoplasms
3
Pancreatic Neoplasms
3
Non-Squamous Non-Small Cell Lung Cancer
3
Neoplasm Metastasis
3
Liver Neoplasms
3
Kidney Neoplasms
3
Esophageal Neoplasms
3
Carcinoma, Hepatocellular
3
Brain Neoplasms
3
Venous Thromboembolism
2
Urinary Bladder Neoplasms
2
Interventions
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Respiratory Tract Diseases
×
Thoracic
×
Clear all
NCT07279935
2026-06-01
REVIVE
AstraZeneca
Phase 4
Recruiting
100 enrolled